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Human Nucleotide Excision Repair Syndromes: 
Molecular Clues to Unexpected Intricacies 
J.H. J. Hoeijmakers 
INTRODUCTION 
THE DEVELOPMENT and maintenance of life has critically 
depended on the evolution of mechanisms that ensure genetic 
integrity and stability. DNA, the vital carrier of genetic infor- 
mation, is continually subjected to undesired chemical alter- 
ations. Numerous environmental or endogenous compounds 
and various types of radiation, such as X-rays and ultra-violet 
(UV) light, induce a wide variety of lesions in the bases, sugars 
or phosphates that make up the DNA. Obviously, such lesions 
(adducts, crosslinks, breaks, etc.) interfere with the proper 
functioning of the genome. An intricate network of DNA repair 
systems constitutes the main barrier protecting against the 
deleterious consequences of DNA injury. This is illustrated by 
the phenotype of inherited defects in one of these repair path- 
ways. Such disorders are invariably associated with a character- 
istic hypersensitivity to a specific class of genotoxic agent. In 
addition, the DNA lesions that persist lead to cellular malfunc- 
tion and to enhanced mutagenesis, due to the increased prob- 
ability that errors occur upon replication of a damaged template. 
Somatic mutagenesis is the initiator of multistep carcinogenesis. 
Rare inborn disorders with hallmarks characteristic of repair 
defects comprise the class of chromosomal instability syn- 
dromes. Well-known examples are Fanconi’s anaemia, ataxia 
telangiectasia and Bloom’s syndrome, all of which display differ- 
ent manifestations of cancer predisposition and increased sensi- 
tivity to specific mutagens. The prototype disorder of this type 
is, however, xeroderma pigmentosum (XP), in which a defect in 
the nucleotide excision repair pathway underlies the pronounced 
predisposition to skin cancer and characteristic photosensitivity. 
The molecular mechanism and biological relevance of this repair 
system constitutes the topic of this chapter. For a comprehensive 
review of DNA damage and the intricate network of DNA repair 
systems in general, the interested reader is referred to Friedberg 
PI. 
Nucleotide excision repair (henceforth abbreviated as NER) 
is one of the most versatile cellular repair mechanisms. This 
universal system eliminates a remarkably diverse array of struc- 
turally unrelated lesions, that range from W-induced photopro- 
ducts (cyclobutane pyrimidine dimers and 6-4 photoproducts) 
to bulky and small chemical adducts as well as intra-strand 
crosslinks. In this light, it is not surprising that the NER process 
entails multiple steps, and involves the concerted action of a 
number of proteins. The details of the reaction mechanism are 
best understood in the case of the UvrABC system in the 
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bacterium Escher&u coli (see [2-51 for recent reviews). Briefly, 
at least six distinct steps can be discerned: lesion recognition and 
lesion demarcation, which involve conformational changes in 
DNA, are carried out by the UvrA2B complex; a complex of 
UvrB and UvrC incises the damaged strand on both sides of the 
lesion at some distance, leaving the non-damaged strand intact; 
the damage-containing oligomer is removed by the helicase 
action of UvrD; and followed by gap-filling DNA synthesis by 
DNA polymerase I; the process is completed by the sealing of 
the new DNA to the pre-existing strand by DNA ligase. In 
principle, this mode of repair is error-free as it utilises the 
nucleotide sequence information of the intact complementary 
DNA strand. 
MOLECULAR INTRICACIES 
Although the outline and concept seem quite simple, it is 
becoming increasingly apparent that the scheme of the NER 
reaction mechanism, as outlined above for E. coli, represents a 
dramatic oversimplification when extrapolated to eukaryotes. 
This notion is based on a number of observations. 
First, a minimum of two, in part, overlapping NER sub- 
pathways have been discovered. One subpathway, here referred 
to as transcription-coupled repair, deals with the complication 
that the vital process of transcription is blocked by lesions in the 
template. To cope with this urgent problem, transcription- 
coupled repair controls the preferential and complete elimination 
of injury in the transcribed strand of active structural genes 
(reviewed in [6, 71). In this specialised NER subpathway, initial 
detection of damage occurs when RNA polymerase II becomes 
blocked in front of a lesion. As part of the reaction mechanism, 
the stalled RNA polymerase complex has to be displaced to give 
the repair machinery access to the injury. Another branch of the 
NER system, here designated global genome repair, 
accomplishes the removal of lesions in the remainder of the 
genome, including the non-transcribed strand of active genes. 
Damage recognition in this repair system is performed by a 
specific NER protein (complexes), and is for many (but not all) 
lesions slower and less efficient compared with transcription- 
coupled repair. The efficiency of damage recognition by the 
global genome repair system varies greatly from lesion to lesion, 
and may also vary with the chromatin conformation, the location 
in the genome and the state of cellular differentiation. This is 
not so surprising considering the tremendous task that is faced 
by this system in continually surveying the 2 m of DNA double 
helix in every mammalian nucleus for trace amounts of a diversity 
of lesions. 
Secondly, as described below, genetic analysis of NER 
mutants and biochemical studies have provided evidence for the 
involvement of more than 20 gene products in the reaction 
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Tabi 1. Main chical features of NER syndnmtss 
Symptoms and signs 
NER syndrome 
XPf cs* PIBIDS 
Sun sensitivity +I+-+ + + 
Pigmentation abnormalities + - _ 
Ichthyosis - - + 
Brittle hair/nails - - + 
Skin cancer ++t - - 
Caries - + + 
Accelerated neurodegeneration -/+* ? ? 
Neurodysmyelination _ + + 
DwarEsm -I? + + 
Impaired sexual development - + + 
* Does not include patients with combined XP/CS. t >2000-fold 
increase. $ Patients belonging to XP group C have no neurological 
abnormalities. XP, xeroderma pigmentosum; CS, Cockayne syndrome; 
PIBIDS, photosensitive tricbothiodystrophy. 
mechanism. These proteins have been conserved to a remarkable 
degree throughout eukaryotic evolution, underlining the funda- 
mental importance of this, process. This makes it likely that the 
mode of action of NER in lower eukaryotes, such as the baker’s 
yeast Sacchromyces cerehsiae, is probably to a large extent 
similar to that in man, although clear differences with the process 
in the prokaryotic model (E. colt) are apparent. 
Furthermore, intimate links between NER and other cellular 
processes have been discltosed, some of which were quite unex- 
pected. Tight coordination of repair and cell cycle regulation 
exists: upon encounterin abnormally high levels of damage, a 
transient block in cell cycle progression is introduced before 
DNA replication or prior to cell division. This gives the repair 
machinery the opportunity to remove the lesions before they 
give rise to permanent, potentially catastrophic changes in the 
genetic material. In addition, connections with recombination, 
replication, chromatin structure and the basic transcription 
apparatus have been unveiled. 
In recent years, there has been spectactular progress in the 
identification of the components and protein complexes involved 
in eukaryotic NER, and details of the underlying molecular 
mechanism are emerging. Before discussing these, however, we 
will first turn to the human syndromes associated with defects in 
NER, which also reveal unexpected intricacies. 
CLINICAL INTRICACIES 
In addition to XP mentioned above, two other human dis- 
orders have been recognised as NER syndromes because of their 
diagnostic sun (UV) sensitivity: Cockayne syndrome and the 
photosensitive form of trichothiodystrophy, also designated 
PIBIDS. Remarkably, the common clinical denominator is 
limited to photosensitivity. In addition, a wide variety of distinct 
symptoms is associated with each of them. As discussed below, 
many of these features are difficult to rationalise with a defect in 
a DNA repair process. The main clinical, biochemical and 
genetic properties of these disorders are summar ised in Tables 1 
and 2. 
XP patients display pronounced cutaneous manifestations. 
Besides acute photosensitivity, one observes strong pigmen- 
tation abnormalities, atrophy and more than a 2000-fold 
increment in all forms of skin cancer, including basal and 
squamous cell carcinomas and melanomas. These are strikingly 
limited to the sun-exposed parts, dramatically demonstrating the 
causative link with the genotoxic effects of the UV component of 
solar light. The frequency of cancer is also elevated for some 
internal tissues, but to a much lesser extent. A significant 
fraction of XP cases exhibit accelerated neurodegeneration, 
consistent with the concept that neurons are very dependent on 
proficient excision repair (Table 1). Cell hybridisation studies 
have led to the identification of seven excision-deficient comp- 
lementation groups within the population of XP patients 
(designated XP-A to XP-G; Table 2) [8]. This implies that 
at least seven distinct genes are involved in this disorder. 
Additionally, a separate category of XP individuals, with a 
presumed defect in the poorly defined postreplication repair 
process, but with apparently normal NER is known. This group 
Tabk 2. Properties of XP, CS and PIBIDS complementation groups 
Complementation UV 
group sensitivity 
Residual 
UDSt 
NER defect* 
TCR GGR Relative frequency 
Overlap with 
other NER 
syndrome Overlap with rodent group 
XP-A 
XP-B 
XP-C 
XP-D 
XP-E 
XP-F 
XP-G 
-ITD-A 
CS-A 
CS-B 
XP-v* 
++ 
++ 
++ 
f 
4% 
<lO% 
15-30% 
15-W% 
>50% 
15-30% 
<lO% 
15% 
wt 
wt 
wt High 
+ + 
+ + 
- + 
+ + 
? ? 
+ + 
+ + 
+(?I + 
+ _ 
+ - 
High 
Three families 
High 
Intermediate 
Rare 
Rare 
Rare 
One family 
Rare 
High 
No 
CS, PIBIDS 
No 
CS, PIBIDS 
No 
No 
cs 
No 
No 
No 
Not groups l-7,11 
Rodent group 3 
Not groups l-6 
Rodent group 2 
Not groups l-3,5 
Rodent group 4? 
Rodent group 5 
Not groups l-3,5,6 
Not known 
Rodent group 6 
No NER defect 
* TCR, transcription-coupled repair; GGR, global genome repair; + , NER subpathway is defective; -, NER subpathway functional. t UDS, 
unscheduled DNA synthesis (expressed as percentage of UDS of normal cells). $ XPV, XP-variant, defective post replication repair, NER normal. 
wt, wildtype; TTD, trichotbiodystmphy. 
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is called the XP-variant (XP-V) and will not be discussed further 
here. For a comprehensive review on the clinical manifestations 
of XP see Cleaver and Kraemer [9]. 
The classical form of Cockayne syndrome (CS) is characterised 
by severe neurological dysfunction (which is, in contrast to XP, 
primarily related to dysmyelination), growth and developmental 
abnormalities, dental caries, wizened appearance and bird-like 
facies. The cutaneous symptoms are limited to sun sensitivity. 
A remarkable feature addressed below is that CS patients do not 
display clear cancer predisposition (Table 1). Complementation 
analysis has defined two CS groups within the classical form of 
the disease: CS-A and CS-B (Table 2) [ 10, 111. The non-classical 
form of CS defines extremely rare individuals with simultaneous 
manifestations of XP and CS. Patients within this subcategory 
are assigned to XP groups B, D and G (Table 2) [8, 121. These 
are also the NER complementation groups which exhibit the 
largest clinical heterogeneity. An extensive overview on the 
manifestations of CS can be found elsewhere [ 131. 
PIBIDS is an acronym for a specific combination of symptoms: 
photosensitivity, ichthyosis, brittle hair and nails, impaired 
intelligence, decreased fertility and short stature. It is a special 
form of a much broader syndrome called Trichothiodystrophy 
(TTD) that also encompases IBIDS, BIDS and SIBIDS patients. 
The clinical hallmark of TTD is brittle hair, which is due to a 
reduced content of a class of matrix proteins with an ultra-rich 
cysteine contact that provides hair with its natural strength. The 
neurological dysfunction is related to neurodysmyelination, as 
in CS. Only the photosensitive subset of TTD patients displays 
a NER defect ([14] and references therein). Cell fusion and 
microinjection of cloned NER genes has also disclosed genetic 
heterogeneity within this NER syndrome. Intriguingly, there is 
again considerable overlap with XP, although the clinical fea- 
tures are very different. Most PIBIDS cases fall into the same 
group as XP-D. Recently, one PIBIDS family was found to 
belong to XP-B, and a third kindred constitutes a distinct NER- 
deficient complementation group, TTD-A, not (yet) associated 
with XP (Table 2) [15, 161. At the clinical level, it is now 
becoming increasingly evident that CS and PIBIDS resemble 
each other much more than previously anticipated (see [ 171 and 
references therein). This concerns the neurological, develop- 
mental (physical and sexual) problems, cutaneous abnormalities 
and the remarkable absence of cancer predisposition (Table 1). 
A complicating factor is that a large fraction of the TTD patients 
exhibits essentially all of the symptoms of PIBIDS, except for 
the photosensitivity, but has no overt repair defect. 
Thus, both genetic heterogeneity within and genetic overlap 
between all NER disorders is found. A specific subset of XP 
groups (notably XP-D and XP-B) is associated with extreme 
clinical variability ranging from XP to CS and PIBIDS. As 
argued at the end of this review, these disorders may in fact be 
considered different manifestations of one heterogeneous clinical 
continuum. In this context, we will also address the puzzling 
connection between defective excision repair and features such 
as brittle hair and nails, neurodysmyelination and impaired 
sexual development. 
OTHER EUKARYOTIC NER MUTANTS 
In addition to the naturally occurring human disorders, a 
large collection of rodent (mainly Chinese hamster) UV-sensitive 
cell mutants has been generated in the laboratory. Comp- 
lementation analysis by cell fusion has identified 11 NER- 
deficient complementation groups among them [18] (see also 
Busch and associates [19] and references therein). Mutants of 
groups l-5 are the most defective in NER and consequently 
display the most pronounced UV-sensitivity. Mutants of groups 
1,4 and to a lesser extent 11 also exhibit an extreme sensitivity 
to crosslinking agents. A subset of rodent mutants appeared to 
be a very valuable source for the isolation of human NER genes 
that correct their repair defect. These genes are termed ERCC 
genes (for excision repair cross-complementing followed by a 
number that refers to the corrected rodent complementation 
group). In this way, ERCCZ-6 have been cloned. Importantly, 
many of these genes were discovered to be implicated in human 
NER disorders (Table 2). Thus, the ERCC2 and 3 genes were 
found to be responsible for XP groups D and B, respectively 
[20,21]. ERCCS corrects the UV sensitivity of XP-G [22, 231, 
whereas the ERCC6 gene was found to be mutated in CS-B [24]. 
Similar experiments on ERCCZ failed to provide a link with any 
of the known XP, CS and TTD complememation groups [25] 
(and Vermeulen, unpublished results). Hence, this gene does 
not (yet) seem to be represented among the identified human 
NER disorders. A similar analysis for the recently cloned 
ERCC4 gene (Thompson, personal communication) is in pro- 
gress, but other findings make XP-F a likely candidate [26, 271. 
Finally, another relevant class of eukaryotic NER mutants is 
presented by the t-ad3 epistasis group ofS. cerez&ae. Within this 
category of UV-sensitive yeast mutants, at least 15 comp- 
lementation groups have been identified. The versatility of 
yeast genetics has permitted the cloning of almost all of the 
corresponding genes, many of which were found to have a 
mammalian counterpart (Table 3). The strong parallels with the 
mammalian system that have emerged in recent years make this 
organism a relevant paradigm for human NER (see [5,27a, 28, 
291 for reviews on yeast NER). 
THE BIOCHEMICAL DEFECT IN - NER 
MUTANTS 
As in yeast and E. coli, a large proportion of the human and 
rodent mutants display defects in both the transcription-coupled 
and global genome subpathways, indicating that their mutation 
affects a step common to or necessary for both modes of NER 
(see also Table 2). This includes mutants of rodent groups l-5, 
and probably 11, and XP groups A, B, D, F, G and TTD-A. 
Biochemical analysis has revealed that incision is completely or 
strongly impaired. This suggests, but does not prove, that the 
mutated proteins are involved in early pre-incision stages of the 
NER reaction. Mutants with disturbances in only one of the 
NER subpathways exhibit an intermediate phenotype, in terms 
of sensitivity and removal of lesions from different parts of the 
genome (Table 2). XP group C carries a defect limited to the 
global genome repair [30]. CS groups A and B as well as rodent 
group 6 are selectively affected in transcription-coupled repair 
[31, 321. The fact that XP-C is associated with strong cancer 
predisposition suggests that the global genome subpathway is of 
major importance for preventing mutagenesis and carcinogen- 
esis. This may provide a plausible explanation why, in CS, no 
significant cancer predisposition is observed; CS patients still 
possess a potent global genome repair system. Furthermore, the 
average age reached by CS patients is only 12.5 years, which is 
quite young in terms of oncogenesis. The transcription-coupled 
repair subpathway may be important for cell survival, but less 
relevant for preventing mutagenesis. 
-IAN NER GENES AND THEIR FUNCTION: A 
POSSIBLE MODEL FOR THE NER REACTION 
A large fraction of the important NER genes involved in the 
seven XP complementation groups has been molecularly cloned. 
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Table 3. Main propertits of cloned human NER genes 
Gene* 
Chromosomal Gene (kb) Protein Yeast 
location size size (aa)t homologue Protein properties* 
XPA 
Xl’BIERCC3 2q21 
XPC 3~25.15 
XPDIERCCZ 
XPE 
XPGIERCCS 
CSBIERCC6 
ERCCl 
ERCC4 
HHR23A 
HHR23B 
p34a=FZ 
19q13.2§ 
11 ? 
13q32-33 -32 
lOqll-21 -85 
19q13.29 15-17 
16~13.3 
llp14-15.1 
sq1.3 
-25 
-45 
? 
273 radll 
782 rad2S(ss12) 
940 rad42 
760 rad3 
1140 Not known 
1186 rad2 
1493 rad26 
297 radl0 
? rod1 
363 rad23 
409 rad23 
548 tfbl 
395 ssll 
303 Not known 
Znz+-finger, binds damaged DNA, transient interaction with ERCCl 
complex 
3’ -+ 5’ DNA helicase, essential for transcription initiation, part of BTFU 
TFIIH 
Limited homology to RAD4, complexed with HHR23B, strong ss-DNA 
binding, involved in GGR only 
5’ + 3’ DNA helicase, essential for transcription initiation, part of BTFZI 
TFIIH 
Binds UV-damaged DNA, no causative mutations identified in XP-E 
patients yet 
Branched DNA-specific ss-endonuclease, 3’-incision 
DNA helicase for displacement of stalled RNA polymerase? nonessential 
function, involved in TCR only 
C-terminal homology to parts of UvrA and C, involved in recombination? 
In complex with ERCC4,11, XPF, ss-endonuclease as complex? 5’- 
incision? 
May be identical to XPF, in complex with ERCCl and 11, ss-endonuclease 
as complex? 
Ubiquitin-like N-terminus. 
Ubiquitin-like N-terminus, complexed with XPC, as complex strong 
ssDNA-binding and involved in GGR only 
Part of BTFZTFIIH, essential for transcription initiation 
DNA-binding Zn 2+-finger? Part of BTFZTTFIIH, essential for 
transcription initiation 
ZnZ+-finger? Part of BTFZTFIIH, essential for transcription initiation 
*Not included in this table are the genes for proteins involved in the DNA-synthesis step of the NER reaction, such as PCNA, hSSB, DNA ligate, 
etc. t aa, amino acids. $ Question marks indicate properties inferred but not proven. TCR, transcription-coupled repair; GGR, global genome 
repair. § The XPC and HHRZ3B genes may share a common 650-kb MluI fragment; ERCCZ and XPDIERCC2 are less than 250 kb apart. 
In addition, one of the two genes implicated in the classical form 
of CS has been isolated, as have several NER genes for which no 
human NER complementation groups are yet known, but for 
which either a rodent mutant or a yeast NER equivalent exists. 
Furthermore, using an in vitro NER assay system based on cell- 
free extracts, several proteins known to be involved in DNA 
replication have also been demonstrated to participate in the 
DNA synthesis step of the NER reaction. 
Computer-assisted comparison of the predicted amino acid 
sequence of the encoded proteins, with known gene products 
present in large databases, has highlighted a striking resemblance 
with NER proteins of the yeast rad3 epistasis group. The extent 
of similarity suggests a ‘golden rule’, namely that for each yeast 
NER protein there is a counterpart in man and vice versa. The 
conclusion must be that the entire NER reaction mechanism is 
strongly conserved in all eukaryotes. The primary amino acid 
sequence also disclosed homology with functional protein 
domains, such as well-chcracterised DNA-binding and helix- 
unwinding sequence motifs. This type of information provided 
valuable clues to the biochemical activity of the encoded polypep- 
tides. Finally, overproduction, purification and enxymological 
characterisation has led to the elucidation of functional proper- 
ties of several of the NER proteins and the identification of 
intricate complexes. Table 3 lists all mammalian NER genes 
cloned to date and summarises their main properties. 
The current knowledge (of NER proteins identified thus far 
can be tentatively integrated into a possible NER reaction 
mechanism. This still highly speculative model is depicted in 
EJC 30:13-8 
Figure lA-F, and each step is discussed below, in terms of the 
available evidence and our still considerable ignorance. 
1. Damage recognition (Figure lA, Table 3) 
A prime candidate for the universal damage recognition factor 
of NER is the XPA protein, possibly with the assistance of the 
XPE factor. 
The XPA gene codes for a 273 amino acid protein with the 
sequence hallmarks of a DNA-binding Zn2+-finger domain [33]. 
The gene product has been purified, and biochemical evidence 
has conlirmed that it is a zinc metalloprotein with affinity for 
double-stranded (ds) and single-stranded (ss) DNA [34-371. A 
marked preference has been found for a number of lesions, 
including ti photoproducts and Cs-Pt adducts, with poor 
binding to cyclobutane pyrimidine dimers [35, 381. This par- 
rallels strikingly the preference of the NER pathway itself, and 
is reminiscent of the lesion-binding spectrum of the E. coli 
UvrA2B complex. Using the in vitro cell-free NER assay, the 
XPA product has been functionally assigned to a step in the pre- 
incision stage of the reaction [39]. These data are consistent with 
the idea that XPA is implicated in damage recognition. 
The 127-kDa protein associated with the XP-E defect was 
puri&d in different laboratories, based on its strong affinity for 
UV-damaged DNA substrates and its high abundance [4043]. 
Microinjection of the protein in XP-E cells induced wildtype 
levels of UV-dependent repair synthesis [44]. The latter finding 
strongly suggests that it is responsible for XP-E. However, 
direct proof that mutations in the gene cause the XP-E defect is 
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Figure 1. Hypothetical model for the molecular mechanism of the 
mammalian nucleotide excision repair reaction. Sequential steps are 
indicated with A-F. See text for a detailed explanation. 
still lacking. The deduced amino acid sequence does not provide 
any clues to the function of the encoded protein, nor has any 
yeast homologue been identified [43]. The XP-E correcting 
factor has a strong preference for binding to DNA containing 6- 
4 photoproducts, with modest discrimination of cyclobutane 
pyrimidine dimers and no measurable affinity for psoralen- 
thymine monoadducts [45]. These lesion-binding characteristics 
are not consistent with it being the universal damage recognition 
factor, but an auxiliary role cannot be ruled out. The striking 
abundance of the protein in normal cells (in the order of lo5 
copies per cell [42]), suggests that it has an additional function. 
A general characteristic of NER factors is that they seem to be 
present only in trace amounts. One possibility is that the XP-E 
correcting protein assists XPA in lesion detection, but direct 
interaction between these polypeptides has not been demon- 
strated. Alternatively, recent evidence suggests that the XPA 
protein may associate transiently with ERCCl ([46, 471, De 
Laat et al., unpublished results, see below), although in crude 
cell extracts, these proteins are not significantly complexed to 
each other (Van Vuuren et al., unpublished results). 
The role of the BTFZITFIIH transcri$tion-repair complex (Fig- 
ure lB-D, Table 3). Many parallels exist between XPD/ 
ERCCZ and XPB/ERCC3 (and their yeast counterparts rad3 and 
rad25, also known as ss12) [21]. Based on the identification of 
helicase motifs in the primary amino acid sequence, Weeda and 
colleagues proposed that both proteins form a complex with 
bidirectional helix-unwinding activity [21]. As apparent below, 
this early idea was corroborated by recent studies. The notion 
that null-alleles of one or both genes in yeast [49, 501, Drosophila 
[5 l] and mouse (Weeda et al., unpublished results) are nonviable 
indicates that these repair proteins must be involved in an 
additional process essential for viability. The nature of the latter 
was elucidated by a surprising discovery made by Egly and 
coworkers [54], who were studing transcription initiation, an 
intricate process like NER, involving the concerted action of 
numerous gene products (for a review see [53]). A multi-subunit 
component, required in a late stage of RNA polymerase II basal 
transcription initiation, is BTFZ, also designated TFIIH. It is a 
complex of at least six polypeptides [54, 551. The two largest 
subunits of this basal transcription factor were found to be the 
repair proteins XPB/ERCC3 [52] and XPD/ERCC2 [56, 571. 
Moreover, purified BTF2 corrects the XP-B, XP-D and TTD- 
A repair defects in viva, as well as in vitro [16, 581, indicating the 
presence of at least three repair proteins in this transcription 
factor, and a striking relationship with NER complementation 
groups involving TTD. Furthermore, the p44 BTF2 subunit 
has recently been identified as the human homologue of the yeast 
ssll protein [59] (see also Table 3). Mutations in this yeast gene, 
originally thought to be involved in translation, give rise to a 
UV-sensitive phenotype [60] consistent with a function in repair. 
Finally, a dominan t mutation in the XPBIERCC3 gene and 
antibodies against XPD protein completely abrogate NER and 
transcription in tivo [16, 581. This establishes the unique dual 
functionality of the complex in repair and basal transcription, 
and extends it to the in viva situation. 
Detection of the primary lesion in the transcription-coupled Purified BTF2 displays the following activities and properties: 
NER subpathway is probably performed by RNA polymerase a DNA-dependent ATPase, a protein kinase phosphorylating 
II. The transcription machinery presumably subjects the DNA 
to a more rigorous test for intactness than achieved via the 
standard NER damage recognition complex. This explains why 
lesions that are poorly removed from the genome overall are 
efficiently eliminated by the transcription-coupled repair mode. 
2. Demarcation of the lesion (Figure lB-D) 
By analogy with the E. coli system, it is plausible that after 
damage detection the DNA and chromatin have to be made 
accessible for recognition by the incision protein complex(es). 
This may involve the induction of a strongly kinked, locally 
unwound, but for all lesions uniform, DNA structure as 
observed with the UvrAzB complex, which overrides the 
aberrant lesion-specific conformation. Currently, no proteins 
have been shown to be associated with this presumed NER 
reaction intermediate. The hSSB complex, composed of three 
subunits of 70,34 and 11 kDa, previously found to be involved 
in initiation and elongation of DNA replication, may act at this 
stage. From studies involving the cell-free in vitro NER assay, it 
appears that this trio of ss DNA-binding proteins plays a role 
prior to or at the incision step [39, 481. As indicated in Figure 
lC, this complex fits well in a model involving a denatured 
intermediate. An additional participant in this stage of the 
reaction could be the BTFZ/TFIIH transcription/repair complex 
which possesses bidirectional helicase activity discussed below. 
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the carboxy-terminus of the large subunit of RNA polymerase 
II, and a bidirectional DNA unwinding activity ([56] and 
references therein). The latter is due to the XPB/ERCC3 
(3’ -+ 5’) and the XPD/ERCC2 (5’ + 3’) helicases. In addition, 
the BTF2 complex is endowed with two proteins (p44 and ~34) 
containing one or more Zn?+-finger domains that may mediate 
DNA and/or protein-protein interactions [59] (Table 3). Studies 
using in vitro transcription initiation assays have not fully 
established the role of BTFZ in transcription initiation. How- 
ever, several plausible models can be advanced. The bidirec- 
tional helicase activity may be required for inducing a specific 
DNA conformation by locally opening the template for loading 
RNA polymerase on to the transcribed strand. Alternatively, or 
in addition, the complex may promote promoter clearance [6 11. 
What possible role could the BTF2 complex have in NER? 
Since BTF2 repair mutant:s show defects in both transcription- 
coupled as well as global genome repair (Table 2), the complex 
probably functions in the core of the NER reaction. Further- 
more, it is reasonable to suppose that BTFZ catalyses a similar 
step in the context of NER and transcription initiation. Thus, 
one of the options is that it induces a denatured DNA confor- 
mation which is required for loading a NER incision complex or 
a lesion-detection complex on to the template and/or for altering 
the DNA conformation around the lesion in a manner similar to 
UvrA,B (see Figure lA-C). Alternatively or in addition, this 
complex may be involved in clearance of the damaged region, 
possibly including release of the damage-containing oligonucleo- 
tide and turnover of repair proteins (Figure l&E). 
3. Dual incision (Figure lD, Table 3) 
Huang and coworkers elegantly demonstrated that the mam- 
malian NER machinery makes a dual incision in the damaged 
strand, involving the fifth phosphodiester bond 3’ and the 2 l-23 
bond 5’ of the lesion [62]. Two strong candidates for this step 
have recently been proposed. The first is a protein complex 
consisting of the ERCCl, ERCC4, ERCCll and XPF proteins 
(the latter may be identical to either ERCC4 or ERCCl 1) [26, 271 
(see also Table 3). The yeast counterpart of this complex, 
comprising radl and 10 proteins, has been shown to possess a ss 
DNA endonuclease activity, that can act on unwound regions of 
negatively supercoiled DNA [63]. This complex is also impli- 
cated in intra-chromosomal mitotic recombination. Both pro- 
cesses encompass DNA irrcision as an obligatory step in their 
reaction mechanism. By analogy to yeast, the human ERCCl 
complex is also predicted to exhibit ss DNA incision activity. A 
second endonuclease activity associated with a repair factor was 
reported for the rad2 [64] and human XPG/ERCCS proteins 
(Wood, personal communication). In contrast to the radl-radl0 
complex, the radf endonucl.ease acts only on ss DNA. Consider- 
ing the fact that both proteins require a ss DNA substrate, it is 
feasible that the DNA around the lesion is locally unwound. 
The bidirectional helicase activity of the BTFZ complex is an 
excellent candidate for this function. Association of the hSSB 
protein complex may prevent the denatured region from rean- 
nealing, and thus facilitate the !irst incision by the radZ-XPG 
endonuclease. This is followed by the second cleavage generated 
by the radl-ERCCl complex, completing the dual incision 
reaction. From recent studies identifying XPG-rad2 as an endon- 
uclease specific for branched DNA structures, the XPG incision 
is most likely 3 ’ to the lesion [65]. 
4. Post in&ion events (Figure lE-F) 
The final stages of the NER reaction should entail release of 
the damage-containing oligomer, turnover of the bound NER 
proteins, gap filling DNA synthesis and sealing of the remaining 
nick by ligation. Currently, it is unknown which protein(s) 
carries out the first of these steps. Again, the BTFZ complex is a 
potential candidate since it harbours two helicases that could 
peel off the injury-containing 27-29-mer. Alternatively, it is 
possible that the DNA replication machinery carries out this 
reaction. 
The use of the cell-free NER assay has permitted the identifi- 
cation of the proliferating cell nuclear antigen (PCNA) as being 
required for the gap-filling DNA synthesis step [39,66]. PCNA 
is known to stimulate DNA polymerase delta and/or epsilon in 
regular DNA replication. Thus, the implication of PCNA 
involvement in this part of the NER reaction mechanism sug- 
gests that the repair synthesis itself is mediated by any or both 
of these polymerases. The final sealing of the new DNA to the 
pre-existing strand is thought to be carried out by DNA ligase I. 
Steps spec$c for the global getwme repair subpathway (Table 3). 
Analysis of mutants has lead to the identification of at least three 
genes selectively implicated in the repair of the non-transcribed 
bulk of the genome: rad7 and radZ6 in yeast [67] and XPC in 
man [30]. 
The XPC amino acid sequence displays significant homology 
to the yeast rad4 protein [68, 691. However, rad4 null mutants 
are, in contrast to XP-C mutants, defective in both NER 
subpathways [67]. This may reflect a principal difference 
between mammals and yeast. The recently purified XPC protein 
(125 kDa) appears to be complexed with HHR23B (43 kDa), 
one of the two human homologues of yeast rad23. Intriguingly, 
the XPC and HHR23B genes are also located very close to each 
other in the genome (at chromosome 3~25, probably within 
650 kb) [70]. The XPC-HHR23B heterodimer has a very high 
affinity for ssDNA, but no associated enzymatic activities have 
been detected [69]. A notable feature of the HHR23 proteins is 
the presence of a ubiquitin-like domain in the N-terminus [69]. 
In some other ubiquitin-fusion proteins, this moiety is thought 
to function as a chaperone, facilitating complex formation. 
Hence this domain may perform a similar role in assembling the 
XPGHHR23B complex. 
In keeping with the golden rule delineated from the striking 
correspondence between yeast and mammalian NER, it would 
be expected that human homologues of rad7 and rad16 also 
exist, and that they participate in the global repair process. The 
rad7 sequence does not reveal any clue to its function [71]. The 
radl6 gene, however, encodes a protein containing a special type 
of DNA-binding Zn z + -finger and an extended region with strong 
homology to a specific subfamily of presumed DNA helicases 
[72]. Interestingly, a protein specific for transcription-coupled 
repair, CSB/ERCC6, is also equipped with such domains [24]. 
A characteristic of other members of this ‘helicase’ subfamily is 
that they reside in multiprotein complexes. Genetic evidence in 
yeast suggests that the complex interacts with chromatin (see 
[73] and references therein). 
In this light, what is the role of the genes mentioned above? 
One possibility, suggested elsewhere, is that they are involved 
in uncoupling essential NER components from the transcription 
machinery to make them available for the global genome repair 
[69]. Obviously, the BTFZ transcription-repair complex is the 
most logical partner in this option. The strong ssDNA binding 
of the XPC complex could release BTFZ from the transcription- 
initiation machinery and make it available for NER. Altema- 
tively, the radl6 protein(complex?) may be implicated in altering 
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chromatin structure required for global genome repair. Obvi- 
ously, these speculations need to be experimentally investigated. 
Steps specific for transcription-coupled repair (Table 3). The only 
isolated eukaryotic gene that is part of the transcription-coupled 
repair process is CSBIERCC6. The not yet cloned gene for the 
CSA protein is anticipated to participate in this system as well. 
CSB/ERCC6 is a member of the closely related subfamily of 
putative DNA/RNA helicases, described above, to which rad16 
also belongs. A yeast homologue of this protein was unknown, 
but the sequence conservation seen for all other eukaryotic NER 
factors permitted the large evolutionary gap between man and 
yeast to be bridged. Like CSB, a yeast disruption mutant 
(designated rad26) displayed a selective defect in transcription- 
coupled repair [73a]. Interestingly, inactivation of this NER 
subpathway in yeast does not induce significant UV sensitivity, 
suggesting that this process is not very important for survival of 
UV-exposed yeast. It is feasible that CSB/ERCC6 and the other 
repair members of this ‘helicase’ subfamily possess a local DNA 
denaturing activity, thereby inducing displacement of bound 
proteins (e.g. nucleosomes or a stalled RNA polymerase 
complex) from the DNA to give repair proteins access to the 
lesion. The possibility exists that the CSB/ERCC6 protein 
functions as a general mediator linking transcription to the total 
of repair pathways. Finally, it should be stressed again that the 
models proposed here are purely hypothetical and serve to 
stimulate design of experimental protocols to verify or dismiss 
them. 
INVOLVEMENT OF TRANSRIPTION DEFECTS IN THE 
COMPLEX NER SYNDROMES 
Clinical heterogeneity and pleiotropy associated with mutations in 
BTF2 
It is clear that the spectrum of diseases linked with mutations 
in the BTF2 subunits XPB/ERCC3, XPD/ERCCZ and TTDA 
is remarkably heterogeneous and pleiotropic, and includes seem- 
ingly unrelated symptoms, such as photosensitivity, brittle hair 
and nails, neurodysmyelination, impaired sexual development, 
ichthyosis and dental caries (see Table 1). The rare XP group B 
and the more common group D are associated with classical XP 
(only in group D), atypical combinations of XP and CS, and 
TTD [ 16, 74, 751 (Table 2). The clinical variability in TTD is 
also apparent from the fact that at least 7 disorders are thought 
to be identical or closely related to TTD. This includes the 
Politt, Tay, Sabinas, Netherton, ONMR, Hair-Brain and the 
Marinesco-Sjiigren syndromes [76]. The occurrence of TTD in 
three distinct NER-deficient complementation groups weighs 
against a chance association between genetic loci separately 
involved in NER and in brittle hair. Consistent with the idea 
that these processes are intimately connected, is the recent 
identification of point mutations in the XPDIERCC2 gene in 
TTD(XP-D) patients [77]. 
The clinical featues derived from the NER defect 
In striking contrast to the pleiotropy and clinical heterogeneity 
selectively associated with XP-B and XP-D, the symptoms seen 
in the most common XP groups A (totally deficient in NER) and 
C (defective in the ‘genome overall’ repair subpathway) are much 
more uniform (Table 2). They involve only photosensitivity, 
pigmentation abnormalities, predisposition to skin cancer and, 
in the case of XP-A, accelerated neurodegeneration (which is 
not associated with neurodysmyelination), but no CS and TTD 
manifestations. The gene products affected in these groups are 
not vital and, therefore, do not appear to be essential for basal 
transcription. This indicates that these forms of XP present the 
manifestations of a pure NER defect. 
Evidence for the involvement of transcriptional defects in CS and 
TTD 
The selective association of BTF2 with the peculiar forms of 
XP and the dual role of this complex in repair and transcription 
make it tempting to link the unexpected TTD and CS features 
with the additional transcription-related function of the NER 
genes involved. Indeed, it would be highly unlikely that all 
mutations in the three subunits of this bifunctional complex 
would affect only the repair function, and leave the inherent 
transcriptional role intact. This interpretation is supported by 
the phenotype of a Drosophila ERCC3 mutant. This mutant 
called haywire displays UV sensitivity, central nervous system 
abnormalities and impaired sexual development, as found in 
XP-B [5 11. Spermatogenesis in Drosophila is very sensitive to the 
level of B2 tubulin [78]. Mutations in the Drosophila ERCC3 
gene seem to affect B tubulin expression, causing male sterility 
[51]. It is, therefore, likely that expression of this gene in 
Drosophila (and by inference possibly in man) is particularly 
sensitive to the level of transcription and thereby to subtle 
mutations in BTFZ. This could explain the immature sexual 
development found in TTD and CS. Expression of the myelin 
basic protein is known to be critically dependent on transcrip- 
tion. Reduced transcription of this gene has been demonstrated 
to cause neurological abnormalities in the mouse [79]. Thus, the 
characteristic neurodysmyelination of CS and TTD [80, 8 l] may 
also relate to suboptimal transcription of this or other genes 
involved in myelin sheet formation. Similarly, reduced tran- 
scription of genes encoding the class of ultrahigh sulphur 
proteins of the hairshaft may account for the observed reduced 
cysteine content in the brittle hair of TTD patients [82]. A 
comparable explanation is proposed for the poor enamelation of 
teeth in CS and TTD [13, 831. The skin abnormalities typical of 
TTD often involve ichthyosis. Various classes of ichthyoses 
show abnormalities in the production of filaggrin [84]. Thus, 
mutations in BTF2 which subtly disturb its transcription func- 
tion may affect a specific subset of genes whose functioning 
critically depends on the level or fine-tuning of transcription. 
Recent studies indicate that the requirement for basal transcrip- 
tion factors may vary from promoter to promoter depending on 
the sequence around the initiation site, the topological state of 
the DNA and the local chromatin structure [85-871. These 
mechanisms can readily explain the pronounced clinical hetero- 
geneity within families. 
As noted previously [17], upon close inspection, many paral- 
lels can be found between CS and TTD suggesting that they are 
manifestations of a broad clinical continuum. This is consistent 
with the finding that mutations in different subunits of the same 
(BTFZ) complex give rise to a similar set of CS and TTD 
features. Thus, defects in CSA and CSBIERCC6 [24] as well as 
XPGIERCCS [12] may also affect basal transcription, as they 
give rise to a comparable phenotype. 
Combined repairltranscription and sole transcription syndromes 
A tentative model proposed for the aetiology of the defects in 
the conglomerate of CS, TTD and related disorders is shown in 
Table 4. In this model, mutations in BTF2 subunits inactivating 
only the NER function result in a XP phenotype as observed in 
the classical XP patients of XP group D. If, in addition the 
transcription function is subtly affected, the combination of XP 
Nucleotide Excision Repair 1919 
Table 4. Dual function of BTFZITFIIH in transcription and 
NER-possible consequences for human disorders 
Function Syndrome Category disorder 
NER inactivated XP* Repair 
Transcription normal 
NER inactivated PIBIDS (XP/CS)t Transcription/Repair 
Transcription partially 
inactivated* 
NER normal T-TDt Transcription 
Transcription partially 
inactivated* 
NER normal or 
inactivated 
Transcription 
inactivateds 
(Lethal) - 
Model for the involvement of defects in transcription and nucleotide 
excision repair in the human disorders xeroderma pigmentosum, 
Cockayne syndrome, trichothodystrophy and a number of related 
diseases. See text for further explanation. 
* NER features: photosensitivity, increased frequency of skin cancer, 
neurodegeneration. t Transcription features: brittle hair (cysteine-rich 
matrix protein), neurodysmyelination (myelin proteins), decreased fer- 
tility (testis-spec.p-2 tubulin?), poor growth, ichthyosis (corniiied envel- 
ope protein?). $ Transcription function subtly affected so mutants still 
viable. $ Transcription function completely inactivated. 
and CS or TTD is found. Theoretically, mutations causing a 
(still viable) transcription problem without NER impairment 
may be expected as well. Indeed, a significant proportion of 
TTD and clinically characteristic CS patients are not noticeably 
photosensitive and have normal NER [88, 891. These findings 
extend the implications to non-repair-defective disorders. 
Therefore, and in view of the pronounced heterogeneity inherent 
to the model, it is possible that the Sjiigren-Larsson (270200), 
RUD (308200), ICE (146728), OTD (257960), IFAP (308205), 
CAM(F)AK (214550), Rothmund-Thompson (268400) and 
KID (242150) syndromes (for references: [76, 901) also fall 
within this category. Interes,tingly, some of these diseases show 
occurrence of skin cancer. 
In conclusion, these findings provide evidence for the presence 
of a wide class of disorders that collectively can be called 
“transcription syndromes”. A prediction from our model is that 
these patients carry mutations in transcription factors, that do 
not affect the NER process. This explanation introduces a novel 
concept into human genetics. It can be envisaged that similar 
phenomena are associated with subtle defects in translation, 
implying the potential existence of “translation syndromes”. 
CONCLUDING RJZMARKS 
After a long period of rstagnation, the field of NER has 
dramatically gained momentum in recent years and is poised for 
further breakthroughs. The basis for this progress has been laid 
by the application of recombinant DNA technology, permitting 
cloning and characterisation of a large set of NER genes, the 
development of a bona fide in vitro assay and the discovery of 
unexpected links with other processes. These findings can now 
be tentatively integrated into a possible model for the complex 
NER reaction. Ahead of us lies the task of unravelling this 
intricate mechanism by filling in the gaps in our perception and 
fitting the pieces of the puzzle together. However, it is not 
difficult to foresee that, within the near future, the core of the 
NER reaction will be reconstituted in vitro using purified 
components. Detailed understanding of the molecular mechan- 
ism of NER is crucial for gaining insight into the specificity, 
efficiency and fidelity of this important pathway for genome 
stability and prevention of cancer. Furthermore, the puzzling 
features associated with a specific subset of NER syndromes 
have found an unexpected but plausible molecular explanation 
by the intimate connection with transcription. The application 
of powerful methodologies to manipulate the mammalian gen- 
ome will allow the generation of a series of mouse models for all 
three NER syndromes. The development of the first NER- 
compromised mouse models has already been welcomed [91] 
(Tanaka, personal communication; Weeda et al., unpublished 
results). This will be of great importance for clinical studies, and 
to assess the biological relevance of the NER system and for 
cancer research in general. 
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INTRODUCTION 
THE MULTI-STEP or multi-hit theory of carcinogenesis states 
that tumour formation is due to the consequences of multiple 
mutagenic events. An obvious conclusion to be drawn from this 
is that predisposition to cancer, due to inherited genetic factors, 
must have an enormous impact on the development of disease. 
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Indeed, intense study of familial cancer, childhood neoplasms, 
onto-viruses and animal models have now identified a large 
number of candidate genes that directly influence the aetiology 
and pathogenesis of many cancers. Although there is no doubt 
that these cancer genes have an important role in tumorigenesis, 
the vast majority of cancers do not appear to have any strong 
familial link. It is now widely accepted that the initiation and 
development of turnours are determined by a delicate balance of 
environmental and host factors. 
